1. Home
  2. ATGL vs TNXP Comparison

ATGL vs TNXP Comparison

Compare ATGL & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATGL
  • TNXP
  • Stock Information
  • Founded
  • ATGL 2017
  • TNXP 2007
  • Country
  • ATGL Hong Kong
  • TNXP United States
  • Employees
  • ATGL N/A
  • TNXP N/A
  • Industry
  • ATGL
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATGL
  • TNXP Health Care
  • Exchange
  • ATGL Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • ATGL 299.1M
  • TNXP 335.6M
  • IPO Year
  • ATGL 2023
  • TNXP N/A
  • Fundamental
  • Price
  • ATGL $32.25
  • TNXP $25.57
  • Analyst Decision
  • ATGL
  • TNXP Buy
  • Analyst Count
  • ATGL 0
  • TNXP 1
  • Target Price
  • ATGL N/A
  • TNXP $70.00
  • AVG Volume (30 Days)
  • ATGL 13.5K
  • TNXP 1.9M
  • Earning Date
  • ATGL 01-01-0001
  • TNXP 08-11-2025
  • Dividend Yield
  • ATGL N/A
  • TNXP N/A
  • EPS Growth
  • ATGL N/A
  • TNXP N/A
  • EPS
  • ATGL N/A
  • TNXP N/A
  • Revenue
  • ATGL $1,590,148.00
  • TNXP $9,831,000.00
  • Revenue This Year
  • ATGL N/A
  • TNXP $21.19
  • Revenue Next Year
  • ATGL N/A
  • TNXP $722.94
  • P/E Ratio
  • ATGL N/A
  • TNXP N/A
  • Revenue Growth
  • ATGL 42.17
  • TNXP N/A
  • 52 Week Low
  • ATGL $1.15
  • TNXP $6.76
  • 52 Week High
  • ATGL $57.32
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • ATGL 67.56
  • TNXP 31.79
  • Support Level
  • ATGL $31.01
  • TNXP $25.33
  • Resistance Level
  • ATGL $35.75
  • TNXP $29.70
  • Average True Range (ATR)
  • ATGL 4.84
  • TNXP 2.47
  • MACD
  • ATGL 0.66
  • TNXP -1.35
  • Stochastic Oscillator
  • ATGL 71.19
  • TNXP 4.22

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: